Altium Capital Management LP Makes New $3.53 Million Investment in NanoString Technologies, Inc. (NASDAQ:NSTG)

Altium Capital Management LP purchased a new position in NanoString Technologies, Inc. (NASDAQ:NSTG) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 54,500 shares of the biotechnology company’s stock, valued at approximately $3,531,000. Altium Capital Management LP owned approximately 0.12% of NanoString Technologies as of its most recent SEC filing.

Several other institutional investors also recently bought and sold shares of the stock. Russell Investments Group Ltd. acquired a new position in shares of NanoString Technologies during the first quarter valued at $216,000. New York State Common Retirement Fund increased its position in shares of NanoString Technologies by 4.2% during the first quarter. New York State Common Retirement Fund now owns 39,900 shares of the biotechnology company’s stock worth $2,622,000 after acquiring an additional 1,600 shares in the last quarter. Teacher Retirement System of Texas raised its holdings in shares of NanoString Technologies by 25.6% during the first quarter. Teacher Retirement System of Texas now owns 4,333 shares of the biotechnology company’s stock worth $285,000 after acquiring an additional 882 shares during the period. Panagora Asset Management Inc. acquired a new position in NanoString Technologies during the 1st quarter worth approximately $2,265,000. Finally, JPMorgan Chase & Co. increased its stake in NanoString Technologies by 33.7% in the 1st quarter. JPMorgan Chase & Co. now owns 384,672 shares of the biotechnology company’s stock valued at $25,277,000 after buying an additional 96,937 shares during the last quarter.

NSTG traded up $0.45 during midday trading on Thursday, hitting $44.55. The stock had a trading volume of 22,297 shares, compared to its average volume of 544,126. The company has a market cap of $2.03 billion, a P/E ratio of -19.13 and a beta of 1.70. The company has a debt-to-equity ratio of 1.02, a quick ratio of 10.14 and a current ratio of 10.81. The business has a fifty day moving average of $53.65 and a 200 day moving average of $59.55. NanoString Technologies, Inc. has a 1 year low of $34.31 and a 1 year high of $86.42.

NanoString Technologies (NASDAQ:NSTG) last posted its earnings results on Wednesday, August 4th. The biotechnology company reported ($0.60) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.56) by ($0.04). NanoString Technologies had a negative return on equity of 45.77% and a negative net margin of 74.15%. The firm had revenue of $33.86 million for the quarter, compared to analysts’ expectations of $32.30 million. The company’s revenue for the quarter was up 49.8% on a year-over-year basis. On average, equities research analysts anticipate that NanoString Technologies, Inc. will post -2.19 earnings per share for the current year.

Separately, Zacks Investment Research cut NanoString Technologies from a “hold” rating to a “sell” rating in a research report on Thursday, September 23rd. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and three have given a buy rating to the company’s stock. Based on data from MarketBeat, NanoString Technologies presently has an average rating of “Hold” and an average price target of $76.20.

In other NanoString Technologies news, Director Kirk Malloy sold 1,500 shares of the business’s stock in a transaction that occurred on Monday, August 16th. The shares were sold at an average price of $55.82, for a total transaction of $83,730.00. Following the sale, the director now owns 8,010 shares of the company’s stock, valued at approximately $447,118.20. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, CFO K Thomas Bailey sold 7,845 shares of the stock in a transaction on Tuesday, August 17th. The stock was sold at an average price of $51.98, for a total transaction of $407,783.10. Following the sale, the chief financial officer now directly owns 5,938 shares in the company, valued at $308,657.24. The disclosure for this sale can be found here. Insiders sold a total of 35,459 shares of company stock valued at $2,082,813 in the last ninety days. 2.80% of the stock is currently owned by insiders.

About NanoString Technologies

NanoString Technologies, Inc engages in the development and commercialization of instruments and services for profiling of genes and proteins from tissue sample. It offers the GeoMx Digital Spatial Profiler and nCounter Analysis System product platforms, both of which include instruments, related consumables, and software.

Recommended Story: What is a Market Correction?

Want to see what other hedge funds are holding NSTG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for NanoString Technologies, Inc. (NASDAQ:NSTG).

Institutional Ownership by Quarter for NanoString Technologies (NASDAQ:NSTG)

Receive News & Ratings for NanoString Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NanoString Technologies and related companies with MarketBeat.com's FREE daily email newsletter.